Abiopharma

News list

📋 ANDREW I KOVEN (Director) plans to sell 14K shares of KALA BIO, INC. (at $0.26 each, total $4K) Filed: Mar 17, 2026 | ID: 002718

Full text

News bot March 17, 2026, 11:14 p.m.
📋 Form 144 Filing: ANDREW I KOVEN

Company: KALA BIO, INC.

Filing Date: 2026-03-17

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 14,466
- Price per Share: $0.26
- Total Value: $3,816.13
- Planned Sale Date: 2026-03-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38150
- Issuer Contact Phone: (781) 996-5252
- Issuer Address: 1167 Massachusetts Avenue, Arlington,, MA, 02476
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 8209725.0
- Number of Securities to be Sold: 1
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock during the period of 06/17/2021 through 01/30/2026.
- Signature: /s/ Andrew Ian Koven